Salem E, Alqahtani S, El-Shoura E, Zaghlool S, Abdelzaher L, Mohamed S
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 40088335
DOI: 10.1007/s00210-025-03920-7.
Oliel Y, Ravona-Springer R, Harel M, Azuri J, Moshe C, Tanne D
Alzheimers Dement (Amst). 2025; 17(1):e70045.
PMID: 40078378
PMC: 11899760.
DOI: 10.1002/dad2.70045.
Hu P, Zou Y, Zhou M, Dai J, Tang X
Quant Imaging Med Surg. 2025; 15(2):1491-1504.
PMID: 39995697
PMC: 11847215.
DOI: 10.21037/qims-24-1591.
Liu D, Li N, Zhu Y, Chen Q, Feng J
BMC Neurol. 2025; 25(1):65.
PMID: 39953442
PMC: 11827292.
DOI: 10.1186/s12883-025-04077-9.
Xiao Y, Hong X, Neelagar R, Mo H
Sci Rep. 2025; 15(1):5011.
PMID: 39929979
PMC: 11811129.
DOI: 10.1038/s41598-025-89374-6.
The mediating role of body surface area-adjusted basal metabolic rate: effects of low muscle mass and central obesity on cognitive impairment in Chinese patients with type 2 diabetes mellitus.
Zhai Y, Li F, Lin C, Wu F, Qiu H, Li J
Front Endocrinol (Lausanne). 2025; 15:1513035.
PMID: 39926391
PMC: 11802378.
DOI: 10.3389/fendo.2024.1513035.
MiR-18a-LncRNA NONRATG-022419 pairs targeted PRG-1 regulates diabetic induced cognitive impairment by regulating NGF\BDNF-Trkb signaling pathway.
Xiang Q, Lin H, Tao J, Fu C, Liu L, Deng J
Proteome Sci. 2025; 23(1):1.
PMID: 39915794
PMC: 11800523.
DOI: 10.1186/s12953-025-00239-2.
Neurocognitive impairment and its associated factors among patients with diabetes mellitus who have follow up at referral hospital in Northwest, Ethiopia.
Simachew A, Getnet A, Minwuyelet F, Mitiku H, Kebede W, Bizuneh F
Front Endocrinol (Lausanne). 2024; 15:1459585.
PMID: 39659614
PMC: 11628274.
DOI: 10.3389/fendo.2024.1459585.
Prognostic effects of glycaemic variability on diastolic heart failure and type 2 diabetes mellitus: insights and 1-year mortality machine learning prediction model.
Yang Z, Li Y, Liu Y, Zhong Z, Ditchfield C, Guo T
Diabetol Metab Syndr. 2024; 16(1):280.
PMID: 39578908
PMC: 11585110.
DOI: 10.1186/s13098-024-01534-2.
Redox regulation, protein S-nitrosylation, and synapse loss in Alzheimer's and related dementias.
Oh C, Nakamura T, Zhang X, Lipton S
Neuron. 2024; 112(23):3823-3850.
PMID: 39515322
PMC: 11624102.
DOI: 10.1016/j.neuron.2024.10.013.
Protective effects of berberine against diabetes-associated cognitive decline in mice.
Gupta M, Rumman M, Singh B, Pandey S
Acta Diabetol. 2024; .
PMID: 39514003
DOI: 10.1007/s00592-024-02411-0.
A pathogenic role for IL-10 signalling in capillary stalling and cognitive impairment in type 1 diabetes.
Sharma S, Cheema M, Reeson P, Narayana K, Boghozian R, Cota A
Nat Metab. 2024; 6(11):2082-2099.
PMID: 39496927
PMC: 11599051.
DOI: 10.1038/s42255-024-01159-9.
Molecular mechanisms of sulforaphane in Alzheimer's disease: insights from an in-silico study.
Vu G, Nguyen H
In Silico Pharmacol. 2024; 12(2):96.
PMID: 39493676
PMC: 11530583.
DOI: 10.1007/s40203-024-00267-4.
Combination treatment with cilostazol and isosorbide mononitrate attenuates microemboli-mediated vascular cognitive impairment and improves imaging and plasma biomarkers in diabetic rats.
Li W, Li A, Nie X, Voltin J, He L, Karakaya E
Exp Neurol. 2024; 383:115030.
PMID: 39490626
PMC: 11629300.
DOI: 10.1016/j.expneurol.2024.115030.
Exercise Promotes Hippocampal Neurogenesis in T2DM Mice via Irisin/TLR4/MyD88/NF-κB-Mediated Neuroinflammation Pathway.
Xu H, Tian X, Wang Y, Lin J, Zhu B, Zhao C
Biology (Basel). 2024; 13(10).
PMID: 39452118
PMC: 11504848.
DOI: 10.3390/biology13100809.
Small heat shock protein B8: from cell functions to its involvement in diseases and potential therapeutic applications.
Chierichetti M, Cristofani R, Crippa V, Ferrari V, Cozzi M, Casarotto E
Neural Regen Res. 2024; 20(10):2872-2886.
PMID: 39435632
PMC: 11826450.
DOI: 10.4103/NRR.NRR-D-24-00517.
Feasibility of an exergaming training program in type 2 diabetes mellitus: A mixed method study.
Savic N, Petry H, de Bruin E, Lehmann R, Eggenberger P, Adcock M
Digit Health. 2024; 10:20552076241285090.
PMID: 39430701
PMC: 11489935.
DOI: 10.1177/20552076241285090.
Abnormal resting-state functional connectivity of hippocampal subregions in type 2 diabetes mellitus-associated cognitive decline.
Yao L, Li M, Wang K, Liu Y, Zheng H, Zhong Z
Front Psychiatry. 2024; 15:1360623.
PMID: 39376966
PMC: 11456530.
DOI: 10.3389/fpsyt.2024.1360623.
Baicalein: A potential GLP-1R agonist improves cognitive disorder of diabetes through mitophagy enhancement.
Liu N, Cui X, Yan W, Guo T, Wang Z, Wei X
J Pharm Anal. 2024; 14(8):100968.
PMID: 39258173
PMC: 11386286.
DOI: 10.1016/j.jpha.2024.100968.
Lifetime history of gestational diabetes and cognitive function in parous women in midlife.
Soria-Contreras D, Wang S, Liu J, Lawn R, Mitsunami M, Purdue-Smithe A
Diabetologia. 2024; 68(1):105-115.
PMID: 39240352
DOI: 10.1007/s00125-024-06270-w.